Granules India Limited (NSE:GRANULES)
India · Delayed Price · Currency is INR 767.95
-21.90 (-2.77%)
Jun 8, 2026, 3:30 PM IST
Granules India Market Cap
Granules India has a market cap or net worth of 190.06 billion as of June 8, 2026. Its market cap has increased by 54.93% in one year.
Market Cap
190.06B
Enterprise Value
195.69B
Revenue
53.66B
Ranking
n/a
PE Ratio
31.94
Stock Price
767.95
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 190.06B, an increase of 116,002.71%. That is a compound annual growth rate of 35.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 195.66B | 34.71% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 374.49B |
| Ajanta Pharma | 371.73B |
| Emcure Pharmaceuticals | 333.07B |
| Wockhardt | 312.13B |
| Piramal Pharma | 221.45B |
| Eris Lifesciences | 189.16B |
| Cohance Lifesciences | 164.92B |
| NATCO Pharma | 160.02B |